Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.68
SciSparc Ltd., a specialized clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. The company is headquartered in Tel Aviv, Israel.
See the full interactive analysis & chart →Informational only — not investment advice.